Pathways to new treatments for heart failure take time—as long as four decades for two now accepted therapies. So, new ...

A Swedish startup wants to democratize stem cell treatments, but the finances of the unproven therapies raise ethical ...

Discover how a BMP-2 loaded scaffold enhances immune cell recruitment for therapeutic applications in regenerative medicine.

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative ...

MEDIPOST, Inc. appoints 5 senior executives as part of the company’s journey to bring its flagship regenerative therapy, CARTISTEM®, to the U.S.

Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disease characterized primarily by the formation of heterotopic ...

An experimental study in mice shows that SARS-CoV-2 infection can damage the retinas, with long-term implications for vision.

Mesoblast Limited announced a key publication in the November 2024 online issue of the prestigious peer-reviewed European Journal of Heart Failure, which re ...

Factors portending the greatest risk for cardiovascular death in control patients were inflammation (baseline plasma high-sensitivity C-reactive protein ≥2 mg/L; p=0.003) and ischemic HFrEF etiology ...

MSCs hold great promise as a therapeutic tool in cancer immunotherapy due to their immunomodulatory properties, tumor-homing ...